Svær asthma bronchiale

Anna von Bülow; Vibeke Backer; Celeste Porsbjerg

Svær asthma bronchiale

Anna von Bülow, Vibeke Backer, Celeste Porsbjerg

Institut for Klinisk Medicin

Abstract

Severe asthma is defined by persistent symptoms and frequent exacerbations despite intensive asthma therapy. The prevalence is estimated to be 5-10% of all asthmatics. Severe asthma is responsible for a major burden of illness including low quality of life and a disproportionate use of health-care resources. The clinical assessment of severe asthma must include verification of the correct diagnosis, adherence to medication, excluding differential diagnosis and identification and treatment of aggravating co-morbidities and trigger factors.

Bidragets oversatte titel	Severe asthma - where are we today?
Originalsprog	Dansk
Artikelnummer	V05130307
Tidsskrift	Ugeskrift for Laeger
Vol/bind	177
Udgave nummer	1
Sider (fra-til)	52-56
Antal sider	5
ISSN	0041-5782
Status	Udgivet - 2015

Citationsformater

@article{fce30d5845434a0c92de3ebb4f97fd76,

title = "Sv{\ae}r asthma bronchiale",

abstract = "Severe asthma is defined by persistent symptoms and frequent exacerbations despite intensive asthma therapy. The prevalence is estimated to be 5-10% of all asthmatics. Severe asthma is responsible for a major burden of illness including low quality of life and a disproportionate use of health-care resources. The clinical assessment of severe asthma must include verification of the correct diagnosis, adherence to medication, excluding differential diagnosis and identification and treatment of aggravating co-morbidities and trigger factors.",

author = "{von B{\"u}low}, Anna and Vibeke Backer and Celeste Porsbjerg",

year = "2015",

language = "Dansk",

volume = "177",

pages = "52--56",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "1",

}

TY - JOUR

T1 - Svær asthma bronchiale

AU - von Bülow, Anna

AU - Backer, Vibeke

AU - Porsbjerg, Celeste

PY - 2015

Y1 - 2015

N2 - Severe asthma is defined by persistent symptoms and frequent exacerbations despite intensive asthma therapy. The prevalence is estimated to be 5-10% of all asthmatics. Severe asthma is responsible for a major burden of illness including low quality of life and a disproportionate use of health-care resources. The clinical assessment of severe asthma must include verification of the correct diagnosis, adherence to medication, excluding differential diagnosis and identification and treatment of aggravating co-morbidities and trigger factors.

AB - Severe asthma is defined by persistent symptoms and frequent exacerbations despite intensive asthma therapy. The prevalence is estimated to be 5-10% of all asthmatics. Severe asthma is responsible for a major burden of illness including low quality of life and a disproportionate use of health-care resources. The clinical assessment of severe asthma must include verification of the correct diagnosis, adherence to medication, excluding differential diagnosis and identification and treatment of aggravating co-morbidities and trigger factors.

M3 - Tidsskriftartikel

C2 - 25347175

SN - 0041-5782

VL - 177

SP - 52

EP - 56

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 1

M1 - V05130307

ER -

Svær asthma bronchiale

Abstract

Fingeraftryk

Citationsformater